Healx
Transforming lives for rare disease patients
Traditional drug discovery is slow, expensive and has a 5% success rate. This has led to a culture of filling pipelines with blockbuster drugs, targeted to large patient populations, in order to offset the cost of failures. By using AI and other frontier technologies to redevelop, combine and enhance known compounds, we are building the next generation of drug discovery so we can bring new, effective therapies to rare disease patients around the world.
Pioneering the next generation of drug discovery
We bring treatments from prediction to patient. Artificial intelligence enables us to rapidly identify which novel drug-disease relationships have the highest chance of success and effectively scale a drug pipeline that will deliver significant patient impact.
By using artificial intelligence to de-risk the drug discovery process, we can run multiple programmes in parallel and deliver a higher chance of treatment success.
Latest news and articles
In the media
Giovanni Cincilla, Peter Wright and Triin Tammsalu explore Target Tractability with KNIME in the latest Medium blog post
News & Opinion
Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences
News & Opinion
Healx and SCI Ventures join forces to uncover cures for paralysis with AI-driven drug discovery
Careers
We’re a diverse team of talented people working to revolutionise the way rare disease treatments are discovered and developed.
Our team has a broad range of expertise, experience, and perspectives but what unites us is our drive to make a positive difference to rare disease patients and their families.